Attenua, Inc.
Records under this name other than the patents Attenua, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,119,659 | (2S, 3R)-N-(2-((3-Pyridinyl)METHYL)-1-Azabicyclo[2.2.2]OCT-3-YL)BENZOFURAN-2-Carboxamide, Novel Salt Forms, and Methods of Use Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 8,541,446 | (2S,3R)-N-(2-((3-Pyridinyl)METHYL)-1-Azabicyclo[2.2.2]OCT-3-YL)BENZOFURN-2-Carboxamide, Novel Salt Forms, and Methods of Use Thereof Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 7,981,906 | (2S,3R)-N-(2-((3-Pyridinyl)METHYL)-1-Azabicyclo[2.2.2]OCT-3-YL-BENZOFURAN-2-Carboxamide, Novel Salt Forms, and Methods of Use Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 8,859,609 | Nicotinic Acetylcholine Receptor Sub-Type Selective Amides of Diazabicycloalkanes Lapsed on the fee record Ended Oct 14, 2026 · Low confidence | Lapsed on the fee record | Ended Oct 14, 2026 | Low confidence |
| US 8,846,715 | (2S,3R)-N-(2-((3-Pyridinyl)METHYL)-1-Azabicyclo[2.2.2]OCT-3-YL)BENZYOFURN-2-Carboxamide, Novel Salt Forms, and Methods of Use Thereof Lapsed on the fee record Ended Sep 30, 2026 · Medium confidence | Lapsed on the fee record | Ended Sep 30, 2026 | Medium confidence |
| US 8,476,296 | Preparation and Therapeutic Applications of (2S,3R)-N-2-((3-Pyridinyl)METHYL)-1-Azabicyclo[2.2.2]OCT-3-YL)-3,5-Difluorobenzamide Lapsed on the fee record Ended Jul 2, 2025 · High confidence | Lapsed on the fee record | Ended Jul 2, 2025 | High confidence |
| US 9,580,434 | Nicotinic Acetylcholine Receptor Sub-Type Selective Amides of Diazabicycloalkanes Formerly held Lapsed on the fee record Ended Feb 28, 2025 · Medium confidence | Lapsed on the fee record | Ended Feb 28, 2025 | Medium confidence |
| US 8,114,889 | Nicotinic Acetylcholine Receptor Sub-Type Selective Amides of Diazabicycloalkanes Lapsed on the fee record Ended Feb 14, 2024 · High confidence | Lapsed on the fee record | Ended Feb 14, 2024 | High confidence |
| US 9,173,876 | Preparation and Therapeutic Applications of (2S,3R)-N-2-((3-Pyridinyl)METHYL)-1-Azabicyclo[2.2.2]OCT-3-YL)-3,5-Difluorobenzamide Lapsed on the fee record Ended Nov 3, 2023 · High confidence | Lapsed on the fee record | Ended Nov 3, 2023 | High confidence |
| US 7,767,193 | 3-Substituted-2(ARYLALKYL)-1-Azabicycloalkanes and Methods of Use Thereof Term ended Term ended Sep 5, 2021 · Medium confidence | Term ended | Term ended Sep 5, 2021 | Medium confidence |